No phaseCompletedGeroscience intervention
Effectiveness of Qualia NAD+ Supplementation on NAD Levels
Effectiveness of Qualia NAD+ Supplementation on Intracellular NAD Levels: A Double-Blind Parallel Trial
- Sponsor
- Qualia Life Sciences (Industry)
- Enrolment
- 92 enrolled
- Conditions
- Intracellular NAD+ Levels
- Interventions
- Qualia NAD+; Rice Flour Placebo
- Ages
- adults, older adults
- Registry
- NCT06812416
Full record on ClinicalTrials.gov
From the registry
The current study is designed as a double-blind placebo-controlled parallel trial. It aims to investigate the efficacy of Qualia NAD+ on intracellular NAD levels in blood samples (primary outcomes) and health-related quality of life (secondary outcomes) in an adult population experiencing moderate to severe joint pain between ages of 40 and 65 years.
Primary outcomes
- Intracellular NAD+ Levels
History
Last registry update
Registered
Primary completion
Started